Old Web
English
Sign In
Acemap
>
authorDetail
>
Xiaoping Zhang
Xiaoping Zhang
Alexion Pharmaceuticals
Internal medicine
Genetics
Mucopolysaccharidosis
Heparan sulfate
Biology
2
Papers
45
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200.
2019
Journal for ImmunoTherapy of Cancer
Daruka Mahadevan
Mark C. Lanasa
Charles M. Farber
Manjari Pandey
Maria Whelden
Susan J. Faas
Terrie L Ulery
Anjli Kukreja
Lan Li
Camille L. Bedrosian
Xiaoping Zhang
Leonard T. Heffner
Show All
Source
Cite
Save
Citations (36)
Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB
2019
Molecular Genetics and Metabolism
Chester B. Whitley
Suresh Vijay
Bert Yao
Mercè Pineda
Geoff J.M. Parker
Sandra Rojas-Caro
Xiaoping Zhang
Yang Dai
Amy Cinar
Gillian Bubb
Kiran C. Patki
Maria L. Escolar
Show All
Source
Cite
Save
Citations (9)
1